FDA on Hot Seat as Congress Probes Compounding Imbroglio
In questioning by members of the House Energy and Commerce Committee, FDA Commissioner Margaret A. Hamburg was hammered for more than four hours Wednesday about the agency's failure to communicate proactively with the Massachusetts Department of Public Health or to provide adequate oversight of the New England Compounding Center, which has been implicated in 32 deaths and more than 400 additional illnesses from a fungal meningitis outbreak across 19 states.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST